FIELD: medicine.
SUBSTANCE: method involves determining prostaglandin E2, arachidonic acid and phosphatidyl inositols in blood sample taken from patient gingiva. The mentioned substance levels data are interpreted in terms of severe, medium or light stage of the disease.
EFFECT: high accuracy of diagnosis.
2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSIS OF PERIODONTAL DISEASES IN PATIENTS WITH BRONCHIAL ASTHMA | 2014 |
|
RU2584028C1 |
| DIAGNOSTIC TECHNIQUE FOR PERIODONTITIS SEVERITY | 2008 |
|
RU2364865C1 |
| METHOD FOR DIAGNOSING PARODONTITIS SEVERITY DEGREE | 2004 |
|
RU2269138C2 |
| METHOD OF DETERMINING DEGREE OF SEVERITY OF PERIODONTITIS | 2012 |
|
RU2473915C1 |
| PERIODONTITIS SEVERITY DIAGNOSTIC TECHNIQUE | 2008 |
|
RU2364871C1 |
| METHOD OF DIAGNOSTICS OF DEGREE OF CHRONIC GENERALIZED PERIODONTITIS IN PREGNANT WOMEN | 2018 |
|
RU2677655C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CHRONIC PERIODONTITIS | 2018 |
|
RU2691304C1 |
| DIAGNOSTIC TECHNIQUE FOR CHRONIC AGGRESSIVE GENERALISED PERIODONTITIS | 2008 |
|
RU2415426C2 |
| DIAGNOSTIC TECHNIQUE FOR PERIODONTITIS SEVERITY | 2008 |
|
RU2386394C1 |
| METHOD FOR PREDICTING THE RISK OF EXACERBATION OF CHRONIC GINGIVITIS IN PATIENTS WITH A NEW CORONAVIRUS INFECTION | 2022 |
|
RU2784295C1 |
